Ken Griffin Volitionrx LTD Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Volitionrx LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 193,745 shares of VNRX stock, worth $122,059. This represents 0.0% of its overall portfolio holdings.
Number of Shares
193,745Holding current value
$122,059% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding VNRX
# of Institutions
29Shares Held
24.2MCall Options Held
0Put Options Held
0-
Lagoda Investment Management, L.P. New York, NY11.7MShares$7.37 Million5.2% of portfolio
-
Armistice Capital, LLC New York, NY8.49MShares$5.35 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$1.02 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA765KShares$481,8810.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$325,1250.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $36.1M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...